Inventor
YOUNG JAMES W
US56 patents
⚠️ This page may combine multiple inventors who share the name “YOUNG JAMES W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SEPRACOR INC
43 patentsUS5786357AJul 28, 1998
Methods and compositions for treating sleep disorders, convulsive seizures and other disorders using optically pure (+) zopiclone
SEPRACOR INC102 citations97
US6369113B2Apr 9, 2002
Method for treating depression using optically pure (−)-bupropion
SEPRACOR INC43 citations96
US6291490B1Sep 18, 2001
Methods and compositions for treating conditions caused by excessive calcium influx in cells using optically pure (-) amlodipine
SEPRACOR INC47 citations96
US6277887B1Aug 21, 2001
Methods for treating Parkinson's disease using optically pure (−)-bupropion
SEPRACOR INC37 citations96
US6057344AMay 2, 2000
Methods for treating hypertension, and angina using optically pure (-) amlodipine
SEPRACOR INC76 citations96
US5962494AOct 5, 1999
Methods for treating behavioral and other disorders using optically pure R(+) ondansetron
SEPRACOR INC56 citations96
US5712302AJan 27, 1998
Compositions using optically pure R(+) ondansetron
SEPRACOR INC37 citations96
US5648396AJul 15, 1997
Methods for treating depression and other disorders using optically pure R (-) fluoxetine and monoamine oxidase inhibitor
SEPRACOR INC56 citations96
US5362755ANov 8, 1994
Method for treating asthma using optically pure (R)-albuterol
SEPRACOR INC60 citations96
US5331000AJul 19, 1994
Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen
SEPRACOR INC88 citations96
US5104899AApr 14, 1992
Methods and compositions for treating depression using optically pure fluoxetine
SEPRACOR INC97 citations96
US6436936B1Aug 20, 2002
Methods and compositions for treating disorders, using optically pure (+) zopiclone
SEPRACOR INC42 citations95
US6451826B2Sep 17, 2002
Optically pure (−) amlodipine compositions
SEPRACOR INC16 citations93
US6451860B1Sep 17, 2002
Methods for treating depression and other disorders using optically pure (−)-bupropion
SEPRACOR INC15 citations93
US6448275B2Sep 10, 2002
Methods for treating hypertension and angina using salts of optically pure (−) amplodipine
SEPRACOR INC21 citations93
US6066654AMay 23, 2000
Methods for treating disorders associated with the central nervous system using optically pure (-) cisapride
SEPRACOR INC16 citations93
US5955478ASep 21, 1999
Methods for treating gastrointestinal motility dysfunction using optically pure (+) cisapride
SEPRACOR INC19 citations93
US5955477ASep 21, 1999
Methods for treating gastrointestinal motility dysfunction using optically pure (--) cisapride
SEPRACOR INC17 citations93
US5919827AJul 6, 1999
Method for treating asthma using optically pure R(-) salmeterol
SEPRACOR INC39 citations93
US5629333AMay 13, 1997
Method treating cognitive disorders using optically pure R(+) ondansetron
SEPRACOR INC27 citations93
US5589511ADec 31, 1996
Method for treating migraine headaches using optically pure S(+) fluoxetine
SEPRACOR INC33 citations93
US5476854ADec 19, 1995
Methods and compositions for treating bacterial infection using optically pure (R)-lomefloxacin
SEPRACOR INC43 citations93
US5470868ANov 28, 1995
Methods for treating emesis and nausea using optically pure R(+) ondansetron
SEPRACOR INC25 citations93
US5375693ADec 27, 1994
Methods and compositions for treating allergic disorders and other disorders metabolic derivatives of terfenadine
SEPRACOR INC101 citations93
US5708035AJan 13, 1998
Methods of use and compositions of R(-) fluoxetine
SEPRACOR INC26 citations92
US5561151AOct 1, 1996
Antipyretic and analgesic methods of using optically pure R-etodolac
SEPRACOR INC28 citations92
US5114715AMay 19, 1992
Methods of use and compositions of (s)-isoflurane and (s)-desflurane
SEPRACOR INC36 citations92
US5114714AMay 19, 1992
Methods of use and compositions of (r)-isoflurane and (r)-desflurane
SEPRACOR INC27 citations92
US6083993AJul 4, 2000
Method for treating bronchospasm using optically pure R(-) albuterol
SEPRACOR INC16 citations84
US5629329AMay 13, 1997
Methods for treating disorders associated with the central nervous system using opticallly pure (+) cisapride
SEPRACOR INC15 citations82
US5629328AMay 13, 1997
Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (+) cisapride
SEPRACOR INC14 citations82
US5618828AApr 8, 1997
Methods for treating gastro-esophageal reflux disease and emesis with optically pure (-) cisapride
SEPRACOR INC16 citations82
US5547994AAug 20, 1996
Method for treating asthma using optically pure R(-) albuterol
SEPRACOR INC18 citations82
US6753338B2Jun 22, 2004
Methods for treating hypertension, angina, and congestive heart failure using of optically pure (-) amlodipine
SEPRACOR INC4 citations74
US5844002ADec 1, 1998
Method for inducing bronchodilation using optically pure R(-) albuterol
SEPRACOR INC9 citations74
US5834496ANov 10, 1998
Methods for treating hypertension using optically pure S(-) felodipine
SEPRACOR INC11 citations74
US5760090AJun 2, 1998
Method for treating asthma using optically pure R(-) albuterol
SEPRACOR INC5 citations74
US5362757ANov 8, 1994
Composition and method containing optically pure (S) metoprolol
SEPRACOR INC8 citations74
US5190962AMar 2, 1993
Treating hypertension
SEPRACOR INC10 citations74
US6337339B2Jan 8, 2002
Methods and compositions for treating infection using optically pure (S)-lomefloxacin
SEPRACOR INC1 citations63
US6274595B1Aug 14, 2001
Compositions for treating infection using optically pure (S)-lomefloxacin
SEPRACOR INC3 citations63
US6075024AJun 13, 2000
Methods for treating infection using optically pure (S)-lomefloxacin
SEPRACOR INC3 citations63
US6069154AMay 30, 2000
Methods for treating gastro-esophageal reflux disease using optically pure (+) cisapride
SEPRACOR INC2 citations63
DRESSER IND
3 patentsSEPRACOR
1 patentUS AGRICULTURE
1 patentMOBAY CHEMICAL CORP
1 patentMOTOROLA INC
1 patentShowing the top 50 of 56 patents by PatentIndex Score.